Kendra Hoyle in Lindale, Texas

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Kendra Hoyle is listed as: Family Practice
Approximate Years of Experience: 27
PAC (PECOS ID)#: 9133032204
NPI #: 1518011642
NPI Created On: 01/23/2007
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207Q00000X
License Number:
L0337
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. X-ray of chest, 2 views
3. Urinalysis, manual test
4. Hemoglobin a1c level
5. Vaccine for influenza for injection into muscle
6. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
7. Routine electrocardiogram (ekg) with tracing using at least 12 leads
8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
9. New patient office or other outpatient visit, typically 30 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Administration of influenza virus vaccine
14. Administration of pneumococcal vaccine
15. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
16. Injection, triamcinolone acetonide, not otherwise specified, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.